Role of Caveolae and Lipid Rafts in Cancer: Workshop Summary and Future Needs

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6571-6574

  Carver, Lucy A ^a   Schnitzer, Jan E ^a   Anderson, Richard G W ^b   Mohla, Suresh ^c  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; LIPID;

CANCER GROWTH; CANCER IMMUNOLOGY; CANCER RESEARCH; CAVEOLA; CONFERENCE PAPER; LIPID COMPOSITION; LIPID TRANSPORT; MEMBRANE BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; HUMANS; MEMBRANE MICRODOMAINS; NEOPLASMS;

EID: 0142157709     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Anderson, R. G., and Jacobson, K. A role for lipid shells in targeting proteins to cavcolae, rafts, and other lipid domains. Science (Wash. DC), 296: 1821-1825, 2002.
2. Edidin, M. Membrane cholesterol, protein phosphorylation, and lipid rafts. http://stke.sciencemag.org/cgi/content/full/oc_sigtrans;2001/67/pc1. Sci STKE, 30 Jan., 2001.
3. Sprong, H., van der Sluijs, P., and van Meer, G. How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell. Biol., 2: 504-513, 2001.
4. Le, P. U., Guay, G., Altschuler, Y., and Nabi, I. R. Caveolin-I is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem., 277: 3371-3379, 2002.
5. Schnitzer, J. E., Oh, P., and MeIntosh, D. P. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes [publisher's erratum appears in Science (Wash. DC), 274: 1069, 1996]. Science (Wash. DC), 274: 239-242, 1996.
6. Schnitzer, J. E., Oh, P., and MeIntosh, D. P. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes [publisher's erratum appears in Science (Wash. DC), 274: 1069, 1996]. Science (Wash. DC), 274: 239-242, 1996.
7. Choudhury, A., Dominguez, M., Puri, V., Sharma, D. K., Narita, K., Wheatley, C. L., Marks, D. L., and Pagano, R. E. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Investig., 109: 1541-1550, 2002.
8. McIntosh, D. P., Tan, X-Y., Oh, P., and Schnitzer, J. E. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc. Natl. Acad. Sci. USA, 99: 1996-2001, 2002.
9. Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J., and Oh, P. Separation of eaveolae from associated microdomains of GPI-anchored proteins. Scienee (Wash. DC), 269: 1435-1439, 1995.
10. Schnitzer, J. E. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deliv. Rev., 49: 265-280, 2001.
11. Pelkmans, L., Kartenback, J., and Helenius, A. Caveolar endocytosis of simian virus 40 reveals a novel two-step vesicular transport pathway to the ER. Nat. Cell Biol., 3: 473-483, 2001.
12. Oh, P., McIntosh, D. P., and Schnitzer, J. E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol., 141: 101-114, 1998.
13. Henley, J. R., Krueger, E. W., Oswald, B. J., and McNiven, M. A. Dynamin-mediated internalization of caveolae. J. Cell Biol., 141: 85-99, 1998.
14. Brown, D. A., and Rose, J. K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell, 68: 533-544, 1992.
15. Rizzo, V., Sung, A., Oh, P., and Schnitzer, J. E. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J. Biol. Chem., 273: 26323-26329, 1998.
16. Rizzo, V., McIntosh, D. P., Oh, P., and Schnitzer, J. E. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J. Biol. Chem., 273: 34724-34729, 1998.
17. Czarny, M., Liu, J., Oh, P., and Schnitzer, J. C. Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide. J. Biol. Chem., 278: 4424-4430, 2002.
18. Liu, J., Oh, P., Horner, T., Rogers, R. A., and Schnitzer, J. E. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem., 272: 7211-7222, 1997.
19. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (Wash. DC), 293: 2449-2452, 2001.
20. Fiucci, G., Ravid, D., Reich, R., and Liscovitch, M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene, 21: 2365-2375, 2002.
21. Feng, D., Nagy, J. A., Hipp, J., Dvorak, H. F., and Dvorak, A. M. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J. Exp. Med., 183: 1981-1986, 1996.
22. Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., and Thompson, T. C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res., 4: 1873-1880, 1998.
23. Yang, G., Truong, L. D., Wheeler, T. M., and Thompson, T. C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res., 59: 5719-5723, 1999.
24. Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., Goltsov, A., Ittmann, M., Morrisett, J. D., and Thompson, T. C. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res., 61: 3882-3885, 2001.
25. Dykstra, M. L., Longnecker, R., and Pierce, S. K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity, 14: 57-67, 2001.
26. Vasile, E., Qu, H., Dvorak, H. F., and Dvorak, A. M. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J. Histochem. Cytochem., 47: 159-167, 1999.
27. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., and Giancotti, F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell, 87: 733-743, 1996.
28. Liu, P., Li, W. P., Machleidt, T., and Anderson, R. G. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nat. Cell Biol., 1: 369-375, 1999.
29. Koleske, A. J., Baltimore, D., and Lisanti, M. P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA, 92: 1381-1385, 1995.
30. Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., and Lisanti, M. P. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem., 272: 16374-16381, 1997.
31. Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., and Schnitzer, J. E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 16: 1391-1397, 1998.
32. Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. G., and Lisanti, M. P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J., 17: 6633-6648, 1998.
33. Bender, F. C., Reymond, M. A., Bron, C., and Quest, A. F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res., 60: 5870-5878, 2000.
34. WAF1/Cip1-dependent mechanism. Mol. Biol. Cell. 12: 2229-2244, 2001.
35. Mouraviev, V., Li, L., Tahir, S. A., Yang, G., Timme, T. M., Gotlsov, A., Ren, C., Satoh, T., Wheeler, T. M., Ittmann, M. M., Miles, B. J., Amato, R. J., Kadmon, D., and Thompson, T. C. The role of caveolin-1 in androgen insensitive prostate cancer. J. Urol., 168: 1589-1596, 2002.
36. Nasu, Y., Timme, T. L., Yang, G., Bangma, C. H., Li, L., Ren, C., Park, S. H., DeLeon, M., Wang, J., and Thompson, T. C. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat. Med., 4: 1062-1064, 1998.
37. Timme, T. L., Goltsov, A., Tahir, S., Li, L., Wang, J., Ren, C., Johnston, R. N., and Thompson, T. C. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene, 19: 3256-3265, 2000.
38. Li, L., Yang, G., Ebara, S., Satoh, T., Nasu, Y., Timme, T. L., Ren, C., Wang, J., Tahir, S. A., and Thompson, T. C. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res., 61: 4386-4392, 2001.
39. Lavie, Y., Fiucci, G., aad Liscovitch, M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem., 273: 32380-32383, 1998.
40. Lavie, Y., Fiucci, G., and Liscovitch, M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv. Drug Deliv. Rev., 49: 317-323, 2001.